The Food and Drug Administration is seeking public comment on a proposal to create a new program to provide earlier access to certain high-risk medical devices.
These are devices that are intended to treat or diagnose patients with serious conditions whose medical needs are not being met by current technology. However, some stakeholders are critical of the approach, labeling it as not new and benefiting only a handful of medical device companies.
Register or login for access to this item and much more
All Health Data Management content is archived after seven days.
Community members receive:
- All recent and archived articles
- Conference offers and updates
- A full menu of enewsletter options
- Web seminars, white papers, ebooks
Already have an account? Log In
Don't have an account? Register for Free Unlimited Access